Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Parker Waichman represents Tennessee man claiming Pradaxa caused cerebral hemorrhage

Filed May 2nd, 2012 Laurie

A Tennessee man has become the latest to file a lawsuit against the makers of the blood-thinning drug Pradaxa, claiming it is responsible for the cerebral hemorrhage he suffered last year.

The national law firm of Parker Waichman LLP is representing the man who had only been taking Pradaxa from late-Feburary through late-April 2011 when he suffered the near-fatal side effect of the drug. The man had been prescribed Pradaxa to prevent stroke and blood clots over the decades-old treatment, warfarin (coumadin).

Since Pradaxa was introduced to the U.S. market in 2010 it has been the source of much speculation and worries over its safety have increased recently, specifically after a report from the makers of the drug, German firm Boehringer Ingelheim linked the drug to at least 260 fatal bleeding episodes, including reports of cerebral hemorrhage. Victims of Pradaxa side effects have also suffered fatal and near-fatal episodes of gastrointestinal hemorrhage.

Late last year, following Boehringer’s report, the Food and Drug Administration announced it was investigating the reports into the deaths to determine if Pradaxa is more dangerous than its predecessor or if increased warnings should accompany the drug when it’s prescribed to patients.

Parker Waichman has filed the lawsuit in U.S. District Court for Connecticut. The Tennessee man claims he suffered a cerebral hemorrhage as well as “physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications, and fear of developing” any of those symptoms in the future, according to a release from the firm announcing the lawsuit.

The firm further claims Boehringer concealed data which highlighted the dangers of Pradaxa and asserts the drug is likely not any safer than warfarin in the prevention of blood clots and stroke. Specifically, the makers of Pradaxa failed to warn the public and regulators that its drug had no antidote, meaning emergency physicians treating a person suffering from a Pradaxa-related bleeding episode are nearly powerless to stop the bleeding from spreading.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!